Dave Meyers is the National Director, Life Sciences Industry in the U.S. Health and Life Sciences group at Microsoft. He is focused on strategy, business development, and managing the portfolio of solutions in pharmaceuticals, medical devices and precision medicine – collaborating with partners and customers to transform their health business. He is passionate about the promise of artificial intelligence, machine learning and genomics and accelerating their impact in healthcare and on individuals’ health.

He joined Microsoft in 1997 - held various technical, program management, and product development positions. He is a graduate from University of Washington’s Foster School of Business and the Public Sector-Healthcare Program from The London Business School and the Genetics and Genomics Program at Stanford University.

He is an active member of HIMSS, HBA, DIA, MRCT-Executive Committee and working with CDISC, TransCelerate, regulators and other industry stakeholders to accelerate scientific innovation for Life Sciences in a responsible and equitable way.

Recent Keynotes/ Publications/Awards:

- PharmaVOICE 100 Most Inspiring People in Life Sciences 2020
- CPhI Festival of Pharma Keynote
- DIA Pharmacovigilance and Risk Management Strategies
- Featured in PharmaVOICE 2020 Year in Preview Magazine
- DIA Annual Meeting Diamond Presentation Future of PharmaTech